Annual Shareholders Equity
$20.47 M
-$13.82 M-40.31%
December 31, 2023
Summary
- As of February 8, 2025, OCX annual stockholders equity is $20.47 million, with the most recent change of -$13.82 million (-40.31%) on December 31, 2023.
- During the last 3 years, OCX annual shareholders equity has fallen by -$13.02 million (-38.87%).
- OCX annual shareholders equity is now -68.62% below its all-time high of $65.22 million, reached on December 31, 2021.
Performance
OCX Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$9.71 M
-$12.99 M-57.23%
September 30, 2024
Summary
- As of February 8, 2025, OCX quarterly stockholders equity is $9.71 million, with the most recent change of -$12.99 million (-57.23%) on September 30, 2024.
- Over the past year, OCX quarterly shareholders equity has dropped by -$27.85 million (-74.15%).
- OCX quarterly shareholders equity is now -90.89% below its all-time high of $106.63 million, reached on March 31, 2021.
Performance
OCX Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
OCX Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -40.3% | -74.2% |
| 3 y3 years | -38.9% | -89.0% |
| 5 y5 years | +498.0% | -89.0% |
OCX Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -68.6% | at low | -89.0% | at low |
| 5 y | 5-year | -68.6% | at low | -90.9% | at low |
| alltime | all time | -68.6% | +2005.8% | -90.9% | +1004.2% |
OncoCyte Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $9.71 M(-57.2%) |
| Jun 2024 | - | $22.70 M(+95.9%) |
| Mar 2024 | - | $11.59 M(-43.4%) |
| Dec 2023 | $20.47 M(-40.3%) | $20.47 M(-45.5%) |
| Sep 2023 | - | $37.56 M(-13.8%) |
| Jun 2023 | - | $43.60 M(+14.9%) |
| Mar 2023 | - | $37.93 M(+10.6%) |
| Dec 2022 | $34.29 M(-47.4%) | $34.29 M(-55.4%) |
| Sep 2022 | - | $76.86 M(-12.8%) |
| Jun 2022 | - | $88.10 M(+54.6%) |
| Mar 2022 | - | $56.97 M(-12.7%) |
| Dec 2021 | $65.22 M(+94.8%) | $65.22 M(-34.4%) |
| Sep 2021 | - | $99.35 M(-3.2%) |
| Jun 2021 | - | $102.67 M(-3.7%) |
| Mar 2021 | - | $106.63 M(+218.5%) |
| Dec 2020 | $33.48 M(+8.6%) | $33.48 M(-3.3%) |
| Sep 2020 | - | $34.64 M(-12.5%) |
| Jun 2020 | - | $39.59 M(+8.1%) |
| Mar 2020 | - | $36.63 M(+18.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | $30.84 M(+800.9%) | $30.84 M(+5.1%) |
| Sep 2019 | - | $29.34 M(-12.4%) |
| Jun 2019 | - | $33.51 M(-12.3%) |
| Mar 2019 | - | $38.19 M(+1015.6%) |
| Dec 2018 | $3.42 M(-22.3%) | $3.42 M(-54.5%) |
| Sep 2018 | - | $7.52 M(+9.9%) |
| Jun 2018 | - | $6.85 M(-24.1%) |
| Mar 2018 | - | $9.02 M(+104.9%) |
| Dec 2017 | $4.40 M(-55.4%) | $4.40 M(-45.3%) |
| Sep 2017 | - | $8.05 M(+42.7%) |
| Jun 2017 | - | $5.64 M(-35.7%) |
| Mar 2017 | - | $8.77 M(-11.0%) |
| Dec 2016 | $9.86 M(-5.3%) | $9.86 M(-22.2%) |
| Sep 2016 | - | $12.68 M(+183.9%) |
| Jun 2016 | - | $4.47 M(-35.2%) |
| Mar 2016 | - | $6.89 M(-33.8%) |
| Dec 2015 | $10.42 M(-1069.9%) | $10.42 M(+16.5%) |
| Sep 2015 | - | $8.94 M(-932.6%) |
| Dec 2014 | -$1.07 M(-129.7%) | -$1.07 M |
| Dec 2013 | $3.62 M | - |
FAQ
- What is OncoCyte annual stockholders equity?
- What is the all time high annual shareholders equity for OncoCyte?
- What is OncoCyte annual shareholders equity year-on-year change?
- What is OncoCyte quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for OncoCyte?
- What is OncoCyte quarterly shareholders equity year-on-year change?
What is OncoCyte annual stockholders equity?
The current annual shareholders equity of OCX is $20.47 M
What is the all time high annual shareholders equity for OncoCyte?
OncoCyte all-time high annual stockholders equity is $65.22 M
What is OncoCyte annual shareholders equity year-on-year change?
Over the past year, OCX annual stockholders equity has changed by -$13.82 M (-40.31%)
What is OncoCyte quarterly stockholders equity?
The current quarterly shareholders equity of OCX is $9.71 M
What is the all time high quarterly shareholders equity for OncoCyte?
OncoCyte all-time high quarterly stockholders equity is $106.63 M
What is OncoCyte quarterly shareholders equity year-on-year change?
Over the past year, OCX quarterly stockholders equity has changed by -$27.85 M (-74.15%)